Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
International Journal of Clinical and Experimental Pathology
|
March 13, 2010
Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers
Michael X Wang, Huan-You Wang, Xiaohui Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity
Babu G Sundar, Thomas R Bailey, Derek Dunn, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2011
4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists
Robert L Hudkins, Lisa D Aimone, Reddeppa Reddy Dandu, et al.
Cell Reports
|
July 6, 2022
Intersectional mapping of multi-transmitter neurons and other cell types in the brain
Jian Xu, Andrew Jo, Raina P DeVries, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2012
4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity
Robert L Hudkins, Allison L Zulli, Reddeppa reddy Dandu, et al.
Journal of Neurotrauma
|
July 1, 1996
MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study
D M Basso, M S Beattie, J C Bresnahan, et al.
Frontiers in Public Health
|
July 5, 2023
The community engagement course and action network: strengthening community and academic research partnerships to advance health equity
Tabia Henry Akintobi, R Barrett, L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 18, 2011
CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities
Rita Raddatz, Robert L Hudkins, Joanne R Mathiasen, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity
Robert L Hudkins, Lisa D Aimone, Thomas R Bailey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2021
Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis
Satoshi Watanabe, Nikolay S Markov, Ziyan Lu, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
International Journal of Clinical and Experimental Pathology
|
March 13, 2010
Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers
Michael X Wang, Huan-You Wang, Xiaohui Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity
Babu G Sundar, Thomas R Bailey, Derek Dunn, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 7, 2011
4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists
Robert L Hudkins, Lisa D Aimone, Reddeppa Reddy Dandu, et al.
Cell Reports
|
July 6, 2022
Intersectional mapping of multi-transmitter neurons and other cell types in the brain
Jian Xu, Andrew Jo, Raina P DeVries, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2012
4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity
Robert L Hudkins, Allison L Zulli, Reddeppa reddy Dandu, et al.
Journal of Neurotrauma
|
July 1, 1996
MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study
D M Basso, M S Beattie, J C Bresnahan, et al.
Frontiers in Public Health
|
July 5, 2023
The community engagement course and action network: strengthening community and academic research partnerships to advance health equity
Tabia Henry Akintobi, R Barrett, L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 18, 2011
CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities
Rita Raddatz, Robert L Hudkins, Joanne R Mathiasen, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 26, 2011
Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity
Robert L Hudkins, Lisa D Aimone, Thomas R Bailey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2021
Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis
Satoshi Watanabe, Nikolay S Markov, Ziyan Lu, et al.
Page
of 7